obesity drugs

7-obesity-drugs-launches

May 12, 2025

9 Promising Obesity Drugs Set to Launch by 2030

pharma-news-for-boston-scientific-roche-northstrive

Apr 29, 2025

Boston Scientific Pushes Forward Despite $200M Tariff Challenge; Northstrive Biosciences Gets FDA Green Light to Advance EL-22 Obesity Trial; Roche Acts Swiftly to Offset U.S. Tariff Impact with Global Engagements; Verastem Oncology Secures IND Clearance for KRAS G12D Inhibitor Trial; BlackfinBio Gets FDA OK for Phase I/II Trial of BFB-101 in SPG47

latest-breakthroughs-obesity-treatment

Mar 26, 2025

The Latest Breakthroughs in Obesity Treatment: A New Era of Weight Loss Innovation

novo-vs-eli-lilly-in-anti-obesity-drug-market

Mar 17, 2025

Novo Nordisk vs. Eli Lilly: The Battle for Anti-Obesity Drug Market Dominance

emerging-therapies-for-obesity-treatment

Mar 14, 2025

Obesity Treatment: Which Pipeline Therapy Will Revolutionize the Therapeutics Segment?

transforming-obesity-treatment

Mar 12, 2025

The Race to Redefine Obesity Treatment

wegovy-for-obesity-and-weight-loss

Mar 12, 2025

WEGOVY: A Leader in the Obesity and Weight Loss Treatment

top-8-obesity-trends

Mar 12, 2025

8 Emerging Obesity Trends Transforming Therapeutics Segment

bariatric-surgery-devices-for-obesity

Mar 12, 2025

How Bariatric Surgery Devices Are Revolutionizing Weight Loss Outcomes?

zepbound-for-obstructive-sleep-apnea

Jan 06, 2025

Lilly’s ZEPBOUND Clears Hurdle in Sleep Apnea Treatment

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper